Related Experiment Video
Updated: Jul 30, 2025
07:01
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.1K
[Antiseizure Drugs].
1Department of Psychiatry, National Defense Medical College.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|May 17, 2023
Summary
Selecting the right antiseizure drugs (ASDs) is crucial for managing epilepsy. Tailor ASD choice to specific seizure types, considering patient factors like comorbidities and reproductive status for effective treatment.
Area of Science:
- Neurology
- Pharmacology
Context:
- Epilepsy management requires precise antiseizure drug (ASD) selection.
- Seizure classification includes focal onset and generalized onset types (e.g., tonic-clonic, absence, myoclonic).
Purpose:
- To guide the selection of antiseizure drugs (ASDs) based on specific seizure types.
- To highlight considerations for patient comorbidities and reproductive status in ASD selection.
Summary:
- Antiseizure drugs (ASDs) must be chosen according to their efficacy for specific seizure types, broadly categorized as focal or generalized onset.
- Careful consideration of patient comorbidities and reproductive age is essential.
- Referral to epileptologists is recommended if seizures persist after trials with two or more appropriate ASDs at optimal doses.
Impact:
- Optimizing ASD selection can improve seizure control and patient outcomes.
- This approach aids clinicians in making informed treatment decisions for epilepsy patients.
- Facilitates timely referral for complex or refractory epilepsy cases.
Related Concept Videos
01:08Antiepileptic Drugs: Sodium Channel Blockers
709
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
709
01:17Antiepileptic Drugs: Calcium Channel Blockers
484
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
484
01:20Antiepileptic Drugs: Potassium Channel Activators
224
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
224
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
475
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
475
01:14Antiepileptic Drugs: Glutamate Antagonists
439
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
439
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
357
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
357